Medicare Enrolled

Dr. Rodolfo Amaro-Galvez, MD

Pulmonary Disease · Tyler, TX
11937 US HIGHWAY 271, Tyler, TX 75708
9038777072
Registered in NPPES since 2005
NPI: 1023006509 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Amaro-Galvez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Amaro-Galvez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Amaro-Galvez

Dr. Rodolfo Amaro-Galvez is a pulmonary disease specialist in Tyler, TX, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Amaro-Galvez received a total of $2,961 from 28 pharmaceutical and/or device companies across 111 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Amaro-Galvez is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration $2,961 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$2,961
Total received (2018-2024)
Avg $423/year across 7 years
Top 43% in TX for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
111
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$517
2023
$329
2022
$866
2021
$365
2020
$56
2019
$526
2018
$302

Payments by company (2024)

ABBVIE INC.
$160
VERTEX PHARMACEUTICALS INCORPORATED
$124
AIMMUNE THERAPEUTICS, INC.
$46
Regeneron Healthcare Solutions, Inc.
$31
VIVUS LLC
$23
Mylan Specialty L.P.
$22
Electromed, Inc.
$20
Paratek Pharmaceuticals, Inc.
$19
GENZYME CORPORATION
$19
ACADIA Pharmaceuticals Inc
$19
Inspire Medical Systems, Inc.
$17
GlaxoSmithKline, LLC.
$17
Top 3 companies account for 63.8% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$342
Chiesi USA, Inc.
$299
VERTEX PHARMACEUTICALS INCORPORATED
$264
GENZYME CORPORATION
$254
Vertex Pharmaceuticals Incorporated
$205
ABBVIE INC.
$201
JAZZ PHARMACEUTICALS INC.
$192
Philips Electronics North America Corporation
$171
AbbVie Inc.
$145
Regeneron Healthcare Solutions, Inc.
$133
GlaxoSmithKline, LLC.
$73
Shire North American Group Inc
$72
Gilead Sciences, Inc.
$68
Genentech USA, Inc.
$62
Mylan Specialty L.P.
$54
Teva Pharmaceuticals USA, Inc.
$52
AIMMUNE THERAPEUTICS, INC.
$46
Baxter Healthcare
$46
Electromed, Inc.
$44
ALCRESTA THERAPEUTICS, INC.
$43
SANOFI-AVENTIS U.S. LLC
$43
Advanced Respiratory, Inc
$37
VIVUS LLC
$23
Nestle HealthCare Nutrition Inc.
$23
Paratek Pharmaceuticals, Inc.
$19
ACADIA Pharmaceuticals Inc
$19
Alcresta Therapeutics, Inc.
$17
Inspire Medical Systems, Inc.
$17
Top 3 companies account for 30.5% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · AirDuo Digihaler · BRONCHITOL · CINRYZE · CREON · Cayston · DAYBUE · DUPIXENT · FASENRA · Hillrom - Vest System Model 105 Home Care · INSPIRE · NUCALA · NUZYRA · ORKAMBI · PERTZYE · ProAir Digihaler · Pulmozyme · QSYMIA · RELIZORB · Respiratoriy Care Undiv · SMARTVEST · SOTROVIMAB · TEZSPIRE · TOBI PODHALER · TRIKAFTA · The MetaNeb System · The Vest System Model 105 Home Care · Tobi Podhaler · Wellcentive Undiv · XYREM · ZENPEP · inCourage
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pulmonary disease specialist in Tyler?
Compare pulmonary diseases in the Tyler area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases in nearby ZIP areas
12
County median income
$71,923
Nearest hospital to ZIP centroid (approximate)
THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT TYLER
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Amaro-Galvez is a pulmonary disease specialist, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Amaro-Galvez receive payments from pharmaceutical companies?
Yes. Dr. Amaro-Galvez received a total of $2,961 from 28 companies across 111 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Amaro-Galvez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Tyler
Browse pulmonary diseases in Tyler ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in TX
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in TX
Which TX pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Chiesi USA, Inc. Payments to Doctors
See all physicians who received payments from Chiesi USA, Inc.
By company
VERTEX PHARMACEUTICALS INCORPORATED Payments to Doctors
See all physicians who received payments from VERTEX PHARMACEUTICALS INCORPORATED.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →